Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22006 | 397 | 32.0 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
365 | 3 | MICROTUBULES//MITOSIS//KINETOCHORE | 34118 |
2644 | 2 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 3490 |
22006 | 1 | DMXAA//FLAVONE ACETIC ACID//5 6 DIMETHYLXANTHENONE 4 ACETIC ACID | 397 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DMXAA | authKW | 2523814 | 11% | 75% | 44 |
2 | FLAVONE ACETIC ACID | authKW | 2053180 | 8% | 86% | 31 |
3 | 5 6 DIMETHYLXANTHENONE 4 ACETIC ACID | authKW | 791117 | 3% | 86% | 12 |
4 | AUCKLAND CANC SOC | address | 732175 | 20% | 12% | 78 |
5 | FLAVONE 8 ACETIC ACID | authKW | 699220 | 3% | 91% | 10 |
6 | ANTIVASCULAR | authKW | 467705 | 4% | 41% | 15 |
7 | 5 6 DIMETHYLXANTHENONE 4 ACETIC ACID DMXAA | authKW | 384572 | 1% | 100% | 5 |
8 | COLON 38 | authKW | 376877 | 2% | 70% | 7 |
9 | ASA404 | authKW | 351602 | 2% | 57% | 8 |
10 | VADIMEZAN | authKW | 175801 | 1% | 57% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5630 | 61% | 0% | 242 |
2 | Pharmacology & Pharmacy | 726 | 26% | 0% | 105 |
3 | Chemistry, Medicinal | 321 | 9% | 0% | 36 |
4 | Radiology, Nuclear Medicine & Medical Imaging | 75 | 7% | 0% | 26 |
5 | Biology | 12 | 2% | 0% | 9 |
6 | Chemistry, Analytical | 10 | 4% | 0% | 15 |
7 | Biochemical Research Methods | 8 | 3% | 0% | 10 |
8 | Nuclear Science & Technology | 7 | 2% | 0% | 8 |
9 | Chemistry, Organic | 6 | 4% | 0% | 14 |
10 | Toxicology | 4 | 2% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AUCKLAND CANC SOC | 732175 | 20% | 12% | 78 |
2 | PLATFORM PEPTID METABOL DRUG MEASUREMENTS | 102551 | 1% | 67% | 2 |
3 | ANTISOMA LTD | 76914 | 0% | 100% | 1 |
4 | CANC BIOL PRECLIN MR IMAGING | 76914 | 0% | 100% | 1 |
5 | CANC CELL 164 | 76914 | 0% | 100% | 1 |
6 | CHIM PARISTECHSORBONNE PARIS CITEINSERMU1022C | 76914 | 0% | 100% | 1 |
7 | CHIM PARISTECHUMR8151U1022 | 76914 | 0% | 100% | 1 |
8 | CURIEUMR3666U1143 | 76914 | 0% | 100% | 1 |
9 | GLYCOCONJUATE | 76914 | 0% | 100% | 1 |
10 | HOSP GINECO OBSTETICIA LUIS CASTELAZO AYALA | 76914 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 17625 | 10% | 1% | 41 |
2 | BRITISH JOURNAL OF CANCER | 7572 | 11% | 0% | 42 |
3 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 4928 | 3% | 1% | 11 |
4 | ONCOLOGY RESEARCH | 2299 | 2% | 1% | 6 |
5 | ANTI-CANCER DRUG DESIGN | 1955 | 1% | 1% | 4 |
6 | INVESTIGATIONAL NEW DRUGS | 1466 | 2% | 0% | 7 |
7 | CANCER RESEARCH | 1304 | 7% | 0% | 26 |
8 | NEOPLASIA | 1133 | 1% | 0% | 5 |
9 | INTERNATIONAL JOURNAL OF HYPERTHERMIA | 983 | 1% | 0% | 5 |
10 | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY | 962 | 2% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DMXAA | 2523814 | 11% | 75% | 44 | Search DMXAA | Search DMXAA |
2 | FLAVONE ACETIC ACID | 2053180 | 8% | 86% | 31 | Search FLAVONE+ACETIC+ACID | Search FLAVONE+ACETIC+ACID |
3 | 5 6 DIMETHYLXANTHENONE 4 ACETIC ACID | 791117 | 3% | 86% | 12 | Search 5+6+DIMETHYLXANTHENONE+4+ACETIC+ACID | Search 5+6+DIMETHYLXANTHENONE+4+ACETIC+ACID |
4 | FLAVONE 8 ACETIC ACID | 699220 | 3% | 91% | 10 | Search FLAVONE+8+ACETIC+ACID | Search FLAVONE+8+ACETIC+ACID |
5 | ANTIVASCULAR | 467705 | 4% | 41% | 15 | Search ANTIVASCULAR | Search ANTIVASCULAR |
6 | 5 6 DIMETHYLXANTHENONE 4 ACETIC ACID DMXAA | 384572 | 1% | 100% | 5 | Search 5+6+DIMETHYLXANTHENONE+4+ACETIC+ACID+DMXAA | Search 5+6+DIMETHYLXANTHENONE+4+ACETIC+ACID+DMXAA |
7 | COLON 38 | 376877 | 2% | 70% | 7 | Search COLON+38 | Search COLON+38 |
8 | ASA404 | 351602 | 2% | 57% | 8 | Search ASA404 | Search ASA404 |
9 | VADIMEZAN | 175801 | 1% | 57% | 4 | Search VADIMEZAN | Search VADIMEZAN |
10 | 3 ARYLFLAVONE 8 ACETIC ACID | 153829 | 1% | 100% | 2 | Search 3+ARYLFLAVONE+8+ACETIC+ACID | Search 3+ARYLFLAVONE+8+ACETIC+ACID |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GOMES, AS , BRANDAO, P , FERNANDES, CSG , DA SILVA, MRPC , DE SOUSA, MEDP , PINTO, MMD , (2016) DRUG-LIKE PROPERTIES AND ADME OF XANTHONE DERIVATIVES: THE ANTECHAMBER OF CLINICAL TRIALS.CURRENT MEDICINAL CHEMISTRY. VOL. 23. ISSUE 32. P. 3654 -3686 | 90 | 48% | 0 |
2 | CHING, LM , (2008) ASA404 VASCULAR-DISRUPTING AGENT ONCOLYTIC.DRUGS OF THE FUTURE. VOL. 33. ISSUE 7. P. 561-569 | 52 | 85% | 3 |
3 | JAMESON, MB , HEAD, M , (2011) PHARMACOKINETIC EVALUATION OF VADIMEZAN (ASA404, 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, DMXAA).EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 7. ISSUE 10. P. 1315 -1326 | 37 | 82% | 3 |
4 | TIJONO, SM , GUO, K , HENARE, K , PALMER, BD , WANG, LCS , ALBELDA, SM , CHING, LM , (2013) IDENTIFICATION OF HUMAN-SELECTIVE ANALOGUES OF THE VASCULAR-DISRUPTING AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA).BRITISH JOURNAL OF CANCER. VOL. 108. ISSUE 6. P. 1306-1315 | 34 | 77% | 12 |
5 | BAGULEY, BC , CHING, LM , (1997) IMMUNOMODULATORY ACTIONS OF XANTHENONE ANTICANCER AGENTS.BIODRUGS. VOL. 8. ISSUE 2. P. 119-127 | 48 | 86% | 25 |
6 | ZHOU, SF , KESTELL, P , BAGULEY, BC , PAXTON, JW , (2002) 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA): A NEW BIOLOGICAL RESPONSE MODIFIER FOR CANCER THERAPY.INVESTIGATIONAL NEW DRUGS. VOL. 20. ISSUE 3. P. 281 -295 | 48 | 71% | 26 |
7 | DAUZONNE, D , MARTINEZ, L , (1995) SYNTHESIS OF THE 3-AMINOFLAVONE-8-ACETIC ACID.TETRAHEDRON LETTERS. VOL. 36. ISSUE 11. P. 1845-1848 | 46 | 90% | 18 |
8 | JAMESON, MB , BAGULEY, BC , KESTELL, P , ZHAO, L , PAXTON, JW , THOMPSON, PI , WALLER, S , (2007) PHARMACOKINETICS OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (AS1404), A NOVEL VASCULAR DISRUPTING AGENT, IN PHASE I CLINICAL TRIAL.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 59. ISSUE 5. P. 681-687 | 26 | 100% | 17 |
9 | RUSTIN, GJS , BRADLEY, C , GALBRAITH, S , STRATFORD, M , LOADMAN, P , WALLER, S , BELLENGER, K , GUMBRELL, L , FOLKES, L , HALBERT, G , (2003) 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), A NOVEL ANTIVASCULAR AGENT: PHASE I CLINICAL AND PHARMACOKINETIC STUDY.BRITISH JOURNAL OF CANCER. VOL. 88. ISSUE 8. P. 1160-1167 | 29 | 91% | 82 |
10 | BIBBY, MC , DOUBLE, JA , (1993) FLAVONE ACETIC-ACID FROM LABORATORY TO CLINIC AND BACK.ANTI-CANCER DRUGS. VOL. 4. ISSUE 1. P. 3-17 | 44 | 88% | 37 |
Classes with closest relation at Level 1 |